Aenova is a leading global contract manufacturer and development service provider for the pharmaceutical and healthcare industries. As a one-stop shop, Aenova develops, produces and packages all common dosage forms, product groups and active ingredient classes of pharmaceuticals and dietary supplements for human and animal health.
Spray drying is an established particle engineering technology that offers several advantages over other methods used for improving API bioavailability.
Lonza’s Robert Beland discusses best practices for manufacturers to shorten development timelines, as well as some of the capabilities at the CDMO's Tampa site.
Lonza exits both softgels and liquid-filled hard capsules and NextPharma plans to broaden its technology offering into lipid based finished dosage forms.